All Change Again for Pharma - Treating the Patient not the Disease After almost 40 years writing about the pharma industry and almost 20 years writing this column I’ve decided to retire. So it’s time to bid you farewell, with a brief look at where we’ve been over these past years, where we are now, and where we might be going with drugs of the future. Death of the Blockbuster? Just a decade ago, with the expiry of the patent on Lipitor it was said we’d seen the death of the b